SCC - SQUAMOUS CELL CARCINOMA
Clinical trials for SCC - SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SCC - SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for SCC - SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection combo shows promise against head and neck cancer
Disease control Recruiting nowThis early-phase study tests a new drug, VLPONC-01, injected directly into head and neck tumors to see if it's safe and can shrink tumors. About 41 adults with advanced head and neck cancer will receive the injection alone or with an immunotherapy drug (pembrolizumab). The goal i…
Matched conditions: SCC - SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: VLP Therapeutics • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
Virus therapy takes on advanced cancers in first human trial
Disease control Recruiting nowThis early-stage study tests a new treatment called MQ710, made from a modified virus, for people with advanced solid tumors that have not responded to standard therapies. The treatment is injected directly into tumors, either alone or with the immunotherapy drug pembrolizumab. T…
Matched conditions: SCC - SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
New PET tracer could spare head and neck cancer patients unnecessary biopsies
Diagnosis Recruiting nowThis early-phase study tests a new radioactive tracer called [18F]NOTA-ABY030, which is designed to make head and neck squamous cell carcinoma show up more clearly on PET/CT scans. About 25 adults with suspicious or unclear findings on standard scans will receive the tracer and u…
Matched conditions: SCC - SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated May 17, 2026 02:08 UTC
-
New scanner could help surgeons remove all cancer in one go
Knowledge-focused Recruiting nowThis study tests a new, high-resolution PET-CT scanner that takes detailed pictures of a tumor right after it is removed during surgery. The goal is to help surgeons see if any cancer cells are left behind, so they can remove more tissue if needed. About 50 adults with solid tumo…
Matched conditions: SCC - SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 02:06 UTC
-
Blood test may predict cancer recurrence in head and neck patients
Knowledge-focused Recruiting nowThis study looks at whether measuring tumor DNA in the blood one month after radiation therapy can help predict if head and neck cancer will come back. About 188 patients with advanced stage III or IV cancer will give blood samples before and after treatment. The goal is to see i…
Matched conditions: SCC - SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Institut de Cancérologie de Lorraine • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC
-
Glowing dye lights up cancer cells to help surgeons remove them
Knowledge-focused Recruiting nowThis early-phase study tests a fluorescent dye attached to the cancer drug panitumumab to make head and neck cancer cells glow during surgery. About 18 adults with head and neck cancer who are already scheduled for surgery will receive the dye infusion before their operation. The…
Matched conditions: SCC - SQUAMOUS CELL CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC